SANTEN PHARMACEUTICAL CO.,LTD.【JP:4536】Balance sheet

Market cap

¥573.5B

P/E ratio

16.3x

Summary Financials Dividends History Ownership Workforce

Income statement Balance sheet Cash flow Other

	2014/03	2015/03	2016/03	2017/03	2018/03	2019/03	2020/03	2021/03	2022/03	2023/03	2024/03	2025/03
Cash and cash equivalents	-	49,114	83,078	32,772	39,579	70,796	91,430	62,888	83,014	57,903	94,582	92,997
Marketable securities, current	-	-	-	-	472	267	452	527	1,293	774	379	997
Accounts receivable, net	-	-	-	-	78,654	84,618	86,999	95,992	99,591	107,165	90,539	71,759
Inventories	-	12,402	13,411	17,368	19,038	35,235	35,282	41,575	37,141	39,352	43,185	51,590
Total current assets	-	150,672	194,739	157,011	139,590	194,742	218,556	206,231	229,426	213,326	236,139	224,300
Property, plant and equipment, net	-	29,104	27,991	28,550	23,135	31,699	35,601	39,489	56,287	66,173	71,576	72,954
Marketable securities, non-current	-	33,349	42,983	28,074	33,823	27,003	27,371	26,429	21,392	20,097	14,270	8,515
Total non-current assets	-	153,528	160,660	165,767	181,238	196,444	190,212	196,122	230,551	207,853	199,560	184,978
Total assets	-	304,200	355,399	322,778	388,463	391,186	408,768	402,353	459,976	421,179	435,699	409,277
Accounts payable	-	-	-	-	29,743	32,079	32,578	38,106	41,185	44,945	43,531	38,989
Short-term debt	-	-	-	-	14,404	12,116	18,777	23,739	38,533	25,858	25,711	25,573
Long-term debt, current	-	11,767	9,524	8,316	4,098	500	3,000	-	-	1,907	-	-
Total current liabilities	-	56,340	73,230	53,434	50,190	60,663	67,597	78,549	95,821	89,504	92,796	86,837
Long-term debt, non-current	-	25,291	12,914	7,598	3,500	8,411	4,992	5,486	11,874	20,000	20,000	20,000
Total non-current liabilities	-	36,081	22,161	15,460	4,873	37,951	38,611	16,754	27,312	38,378	37,534	37,260
Total liabilities	-	92,421	95,391	68,894	100,905	98,614	106,208	95,303	123,133	127,883	130,329	124,096
Common stock and paid-in capital	-	15,460	16,084	16,278	33,447	34,111	34,539	35,245	36,086	36,590	36,880	36,909
Retained earnings	-	178,840	221,945	223,418	233,493	258,659	273,422	270,757	290,477	238,071	240,029	228,291
Stockholders' equity	180,598	203,211	252,151	245,358	265,765	292,572	302,560	307,050	336,844	293,297	305,369	285,181

Raw aggregated data